Sign in

You're signed outSign in or to get full access.

Adrienne O'Neill

Executive Vice President and Chief Accounting Officer at METLIFEMETLIFE
Executive

About Adrienne O'Neill

Adrienne O’Neill is Executive Vice President and Chief Accounting Officer at MetLife (effective September 2, 2025). She is 44 years old, holds a BBA (Honors) from Wilfrid Laurier University, and is both a CFA and CPA (recognized as a CPA fellow in 2023) . Her remit spans corporate accounting, external reporting, and FP&A; compensation will follow MetLife’s pay-for-performance framework where variable pay is aligned to Adjusted ROE and relative TSR via performance shares . Company performance context: 2024 net income was $4.426B and revenues were $70.046B; EBITDA was $6.259B (see table below) * *.

Past Roles

OrganizationRoleYearsStrategic Impact
Manulife Financial Corp.CFO, Asia SegmentFeb 2025–Feb 2025Led finance for Asia, overseeing multi-country performance and planning .
Manulife Financial Corp.Global Controller & Group Chief Accounting OfficerJul 2021–Feb 2025Directed global accounting policy, controls, and external reporting .
Manulife Financial Corp.Global Head of Investor RelationsSep 2018–Jun 2021Led capital markets communications and investor engagement strategy .
Manulife Financial Corp.Various roles in Global Wealth & Asset Management, General Account Investments, Canadian Segment2007–2018Built multi-asset finance, investments, and business unit experience .

External Roles

None disclosed beyond professional recognitions (CPA fellow in 2023) .

Fixed Compensation

ComponentTermsEffective/Grant TimingNotes
Base Salary$525,000 per annumEffective Sep 2, 2025Per 8-K appointment .
Annual Incentive (AVIP)Discretionary incentive award; 2025 pro-ratedAnnual cycleDetermined per MetLife plans and Committee assessment .
Sign-on CashEligible for certain sign-on cash paymentsNear start dateIntended to replace forfeited compensation (amounts not disclosed) .

Performance Compensation

Incentive TypeMetricWeightingTargetActual/PayoutVesting
Performance Shares (LTI)Adjusted ROE vs Business PlanPart of 70% perf-based LTICompany-set; not disclosed for O’NeillNot applicable yetThree-year overlapping periods .
Performance Shares (LTI)TSR relative to peersPart of 70% perf-based LTICompany-set; not disclosed for O’NeillNot applicable yetThree-year overlapping periods .
Restricted Stock Units (LTI)Share value at settlementRemainder of LTINot applicableNot applicable yetTypically vest one-third annually over 3 years; some awards cliff-vest at 3 years .
Sign-on Stock-Based LTIReplacement awardsAggregate grant date value $1,950,000Not applicableReplacement onlyIntended to replace forfeited comp; structure (RSU/PSU) not disclosed .

MetLife’s annual AVIP funding is based on performance vs Business Plan; individual awards reflect holistic Committee assessments without formulaic individual targets .

Equity Ownership & Alignment

  • Sign-on stock-based LTI award aggregate grant date value of $1,950,000; structure not disclosed .
  • Executive share ownership guidelines apply to SVP+ (retain 100% of net shares until guideline met; guidelines vary by role; NEO examples range from 4x base salary to 7x for CEO) .
  • Hedging and pledging are prohibited for directors and employees, including executive officers .
  • Clawback policies: performance-based recoupment for misconduct or materially inaccurate metrics, and mandatory recovery for certain restatements under Dodd-Frank, regardless of fault .

Employment Terms

ProvisionTermsNotes
Employment AgreementU.S.-based executive officers do not have individual employment contractsProgrammatic plans govern; consistent disclosure .
Severance (No CIC)Officer-level program: 28 weeks base salary + 1 week per year of service (cap at 52 weeks); half-sized payout if terminated for performanceRequires separation agreement; outplacement provided .
Change-in-Control (CIC)Double-trigger only; up to 2x total annual cash comp (salary + average annual cash incentive); no excise tax gross-upLTI may be substituted by equivalent value awards; otherwise vesting accelerates on CIC .
Death/DisabilityImmediate vesting of unvested PSUs at target and RSUs; options become fully exercisable through expirationLump-sum settlement .
Award Timing PracticesRegular LTI grants in February; new-hire grants timed to forfeited awards and role changes; no MNPI timingNo options/SARs granted within blackout window tied to MNPI filings .

Performance & Track Record

  • Deep finance leadership across accounting, reporting, FP&A, IR, and investments from 18 years at Manulife, culminating in CFO Asia and Group CAO roles .

  • Company-level performance context (USD):

    MetricFY 2022FY 2023FY 2024
    Revenues ($)68,729,000,000*68,839,000,000*70,046,000,000
    EBITDA ($)4,294,000,000*2,925,000,000*6,259,000,000*
    Net Income ($)5,284,000,000*1,578,000,000*4,426,000,000

    Values retrieved from S&P Global.*

Governance, Risk Indicators & Shareholder Feedback

  • Say-on-pay support: 95% approval in 2024; long-term average ~96% since 2011 .
  • No repricing of options without shareholder approval; no single-trigger CIC severance or vesting; no excise tax gross-ups and limited tax gross-ups (relocation/transition only) .
  • Insider trading policy prohibits hedging/pledging; strong risk oversight via three lines of defense and multi-committee board oversight .

Compensation Structure Analysis

  • High variable pay orientation: majority of executive Total Compensation is performance-linked and share-based, with 70% of LTI in performance shares tied to Adjusted ROE and relative TSR .
  • Sign-on stock LTI ($1.95M) indicates retention-focused design to replace forfeited compensation, aligning incentives to remain through vesting cycles .
  • Program avoids shareholder-unfriendly practices (no pledging/hedging, no option repricing, no excise tax gross-ups) and applies robust clawbacks .

Investment Implications

  • Alignment: Base salary of $525k with AVIP and performance share-heavy LTI should align O’Neill’s incentives with Adjusted ROE and relative TSR performance, consistent with MetLife’s pay-for-performance design .
  • Retention and potential supply: Sign-on LTI and standard 3-year vesting cadence can reduce near-term selling pressure; policy prohibitions on hedging/pledging lower alignment risk .
  • Downside protection: No single-trigger CIC; capped CIC severance (≤2x cash) and strong clawbacks limit adverse shareholder outcomes in transitions or restatements .
  • Context: 2024 financials improved versus 2023 and strong say-on-pay support (95%) reduce governance and payout risk while reinforcing credibility of the incentive framework * .